[A new topical carbonic anhydrase inhibitor (MK-927). Tolerance comparison with betaxolol in healthy probands]

Autor: B, Feicht, H M, Hofmann, E, Lippa, F, Brunner-Ferber, H, von Denffer, H J, Merté
Jazyk: němčina
Rok vydání: 1990
Předmět:
Zdroj: Klinische Monatsblatter fur Augenheilkunde. 197(3)
ISSN: 0023-2165
Popis: MK-927 is a new topical carboanhydrase inhibitor with proven ability to lower intraocular pressure in glaucoma patients. Subjective and objective symptoms following topical application of MK-927 were evaluated in a randomized, double-blind, placebo-controlled study in which 24 healthy male volunteers took part. Symptoms were rated according to a visual analog scale by the volunteers and according to a grading scale by the examiner. The study showed good local tolerance of MK-927, comparable to that of Betaxolol.
Databáze: OpenAIRE